Ken Griffin’s Medline MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$72.3M Buy
2,082,861
+2,050,275
+6,292% +$75M 0.01% 1230
2026
Q2
$1.29M Sell
32,586
-1,560,772
-98% -$62.9M ﹤0.01% 7584
2026
Q1
$70.9M Sell
1,593,358
-4,412,981
-73% -$195M 0.01% 1069
2025
Q4
$252M Buy
+6,006,339
New – 0.04% 399

Other funds holding MDLN

Ken Griffin's MDLN Position: Q3 2026 in Review

Ken Griffin increased its Medline (MDLN) stake by 6,292% in Q3 2026, buying an estimated $75M and bringing the position to 2,082,861 shares worth $72.3M. The position accounts for 0.01% of the portfolio, ranked #1230.

Ken Griffin first reported a position in MDLN in Q4 2025 and has held it in 4 quarters since. The position peaked at $252M in Q4 2025. 415 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • Ken Griffin held 2,082,861 shares of Medline worth $72.3M as of Q3 2026.
  • Ken Griffin bought 2,050,275 Medline shares in Q3 2026, an estimated $75M.
  • Medline made up 0.01% of Ken Griffin's portfolio in Q3 2026, its #1230 holding.
  • Ken Griffin first reported a position in Medline in Q4 2025 and has held it in 4 quarters since.
  • Ken Griffin's Medline position peaked at $252M in Q4 2025.
  • 415 funds tracked by Wall St. Rank held Medline as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.